Search
for
Sort by
Research 91–120 of 136
- The therapeutic efficacy of mesenchymal stem cells and their extracellular vesicles in the treatment of diverse skin diseases
- Associations Between Skin Microbiome and Metabolome in the Pathogenesis of Atopic Dermatitis Patients With Scalp Involvement
- Gut microbiome, metabolome and alopecia areata
- Cannabinoids for the Treatment of Hair, Scalp, and Skin Disorders: A Systematic Review
- Common Skin Diseases and Metabolic Syndrome: A Proinflammatory Chemokine Perspective
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Hypothesis: platelet-rich plasma as an adjunct therapy for eczema targeting inflammation, skin barrier repair, and chronic recurrence
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Stem Cell Use to Treat Dermatological Disorders
- Hypochlorous Acid: Clinical Insights and Experience in Dermatology, Surgery, Dentistry, Ophthalmology, Rhinology, and Other Specialties
- The JAK/STAT signaling pathway: from bench to clinic
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Poster Presentations
- Blue Light in Dermatology
- Nutritional and Microbial Strategies for Treating Acne, Alopecia, and Atopic Dermatitis
- Human umbilical cord mesenchymal stem cell therapy for atopic dermatitis through inhibition of neutrophil chemotaxis
- The Role of the Gut Microbiome and Microbial Dysbiosis in Common Skin Diseases
- Comprehensive Insight into Cutaneous Application of Hemp
- UV Protection Habits and Preferences in Patients With Distinct Cutaneous Immune‐Mediated Inflammatory Diseases
- Insulin Resistance, Metabolic Syndrome, and Inflammatory Skin Disease
- Inflammatory Skin Disease in Latin America: Treatment Challenges and Opportunities
- Utilization of Stem Cells in Medicine: A Narrative Review
- Unique Circulating MicroRNA Signatures Distinguish Severe Alopecia Areata from Other Inflammatory Skin Diseases
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Strategies for High-Efficiency Mutation Using the CRISPR/Cas System
- Signs of physical abuse and neglect in the mature patient
- Tralokinumab Treatment in Adult Atopic Dermatitis Patients: 28‐Week Evaluation of Clinical Effectiveness, Safety, Serum Proteins and Total IgE Levels
- Tapinarof cream for atopic dermatitis: Pharmacokinetics, systemic exposure, and preliminary efficacy/safety results
- Teriflunomida and hair disorders